tissue-based diagnostics
Tissue-Based Drug Screening Platform Shows Potential to Improve Precision Brain Tumor Treatment
Premium
In a study by UNC researchers, all brain tumor samples grown on rat brain slices engrafted successfully and retained significant genetic similarity to the parent tumor.
PARP Inhibitors Show Frontline Prostate Cancer Benefit; Conflicting Biomarker Data Raise Questions
Premium
Merck and AstraZeneca's Lynparza benefited patients regardless of HRR gene mutation status, while Janssen's niraparib only benefited a biomarker-defined group.
Qiagen, Mirati Therapeutics Partner to Develop KRAS Companion Test for NSCLC Drug
The tissue-based test will identify cancer patients who may benefit from adagrasib, Mirati's investigational oral small molecule inhibitor of KRAS G12C.
FDA Clears Cancer Genomic Profiling Kit From Personal Genome Diagnostics
The firm said the FDA clearance was supported by data across several lab sites and all variant classes in clinical samples from 35 tumor types.